Randomized clinical trials establish high-flow nasal cannula effectiveness in diverse hospital settings, suggesting broad utility in respiratory care.
High-flow nasal cannula (HFNC) has become a cornerstone of contemporary respiratory support.(1,2) Initially introduced as an easy-to-use, simple, and comfortable alternative for respiratory support in hypoxemic respiratory failure in the intensive care unit, its indications have expanded rapidly across hospital settings, patient populations, and clinical contexts.(3-6) Randomized clinical trials have established HFNC as an effective […]
No takes yet. Share an insight, caveat, or question.
Maia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: